University of Rhode Island

DigitalCommons@URI
Open Access Dissertations
2021

PSYCHOMETRIC PROPERTIES AND GENERATIONAL
DIFFERENCES IN SELFREPORTING ON THE CLINICALLY USEFUL
SUBSTANCE ABUSE PROBLEMS OUTCOMES SCALE
Donya Sorensen
University of Rhode Island, donyasorensen@gmail.com

Follow this and additional works at: https://digitalcommons.uri.edu/oa_diss

Recommended Citation
Sorensen, Donya, "PSYCHOMETRIC PROPERTIES AND GENERATIONAL DIFFERENCES IN
SELFREPORTING ON THE CLINICALLY USEFUL SUBSTANCE ABUSE PROBLEMS OUTCOMES SCALE"
(2021). Open Access Dissertations. Paper 1290.
https://digitalcommons.uri.edu/oa_diss/1290

This Dissertation is brought to you for free and open access by DigitalCommons@URI. It has been accepted for
inclusion in Open Access Dissertations by an authorized administrator of DigitalCommons@URI. For more
information, please contact digitalcommons@etal.uri.edu.

PSYCHOMETRIC PROPERTIES AND GENERATIONAL DIFFERENCES IN SELFREPORTING ON THE CLINICALLY USEFUL SUBSTANCE ABUSE PROBLEMS
OUTCOMES SCALE

DONYA J. SORENSEN
UNIVERSITY OF RHODE ISLAND

A DISSERTATION SUBMITTED IN PARTIAL FULFILLMENT OF THE
REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY IN
PSYCHOLOGY

UNIVERSITY OF RHODE ISLAND
2020

DOCTOR OF PHILOSOPHY DISSERTATION
OF
DONYA J. SORENSEN

APPROVED:
Dissertation Committee:
Major Professor

Mark Robbins
Andrea Paiva
Phillip Clark
Kristy Dalrymple
Brenton DeBoef
DEAN OF THE GRADUATE SCHOOL

UNIVERSITY OF RHODE ISLAND
2020

Abstract
Substance abuse is a growing problem worldwide, and the negative consequences
associated with Substance Use Disorder (SUD) impact people across all age groups, but
the availability of SUD screening tools that show clinical usefulness across generational
differences is limited. Therefore, more research exploring differences and similarities in
substance abuse and dependence problems across age groups may provide useful
information for future research and clinical work. The present study examines age group
differences in substance abuse and dependence behaviors in three main analyses.
First, age differences in abuse and dependence of drug types were examined
using Chi-square tests for independence with a sample (N = 1,620) who completed
Structured Clinical Interviews for DSM (SCID) interviews as part of the MIDAS study at
Rhode Island Hospital. Participants reported on whether they abused different drug types
(i.e., sedatives/hypnotics/anxiolytics, cannabis, stimulants, opioids, cocaine, and
hallucinogens) in the past year. Crosstabulations comparing abuse and dependence of
different drug types across age groups (i.e., ages 18-25, 26-35, 36-49, 50 and older),
showed that the middle age group (i.e., ages 36-49) reported significantly higher rates of
past-year substance abuse and dependence compared to the other age groups, for drug
types including sedative/hypnotics/anxiolytics, cannabis, stimulants, and cocaine. In
addition, past-year cannabis abuse appeared to be significantly more prevalent across all
age groups compared to other drug types.
Second, the factor structure of a proposed substance abuse problems measure, the
Clinically Useful Substance Abuse Problems Outcome Scale (CUSAPOS), was explored
with principal components analysis (PCA) and confirmed with confirmatory factor

analysis (CFA) in order to evaluate clinical usefulness in an outpatient psychiatric
setting. Results from PCAs showed that the proposed CUSAPOS subscales, which assess
for alcohol and drug abuse problems, should be treated as two distinct scales, the
Clinically Useful Alcohol Problems Outcomes Scale (CUAPOS) and the Clinically
Useful Drug Problems Outcome Scale (CUDPOS), each with two factors. Both scales
show one factor that appears to describe the level of one’s insight regarding their
substance abuse problems, and the other factor assessing for behavioral consequences of
substance abuse problems. The factor structure for each scale was confirmed with CFAs
examining overall goodness of fit. Multigroup CFA was used to test for invariance of
participant responses to these scales across four Age Cohorts including Young Adults
(ages 18-25), Adults (ages 26-35), Middle Age (ages 36-49) and Older Adults (ages 50
and older). Results showed that both the CUAPOS and the CUDPOS are non-invariant,
suggesting that there may be meaningful differences in the way participants in different
age cohorts interpreted and responded to the proposed items in each scale.
Third, after confirming the factor structure of the two distinct scales and
establishing that they are both non-invariant across Age Cohorts, differences in
participants mean scores were examined between Age Cohorts for both the CUAPOS and
the CUDPOS with Analyses of Variance (ANOVAs). Confounding variables that
potentially influence relationships between age and alcohol or drug abuse, including
Race, Gender, Mood Impairment, Attention Deficit Hyperactivity Disorder (ADHD),
Self-Injury, and Childhood Trauma were analyzed using ANCOVAs and two-way
ANOVAs. ANOVA results showed that the CUAPOS showed no significant differences
in mean scores between Age Cohorts, however an interaction effect between Age Cohort

and Race showed that the Young Adult, Persons of Color, group reported significantly
less problems than the rest of the Age Cohort and Race groups, whereas the Middle Age,
Person of Color group reported significantly more alcohol problems compared to the
other groups. The CUDPOS showed significant differences in the mean scores between
the Young Adult group and the Middle Age and Older Adult groups. Gender was found
to have a significant main effect on CUDPOS scores but showed a nonsignificant
interaction effect with Age Cohort. Overall, results showed that the only significant
covariate influencing the relationship between the participant responses on the CUDPOS
between Age Cohorts was Childhood Trauma. Implications of these findings and study
limitations are discussed, as well as suggestions for future research further exploring
relationships between age and substance abuse and dependence.
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Introduction
Substance Use Disorder (SUD), described in the DSM 5 as “a maladaptive pattern
of substance use leading to clinically significant impairment or distress,” is a growing
concern in the U.S. population. However, little is known regarding appropriate
assessment and treatment of substance abuse problems across demographic groups,
particularly in terms of age, race, and gender differences. While valid and reliable
substance abuse screening tools exist, many are limited in their ability to describe the
nature and severity of substance abuse problems. The present study examines the
psychometric properties of a novel substance abuse scale, the Clinically Useful Substance
Abuse Problems Outcome Scale (CUSAPOS), in order to evaluate clinical usefulness in
an outpatient psychiatric setting.
Substance abuse is a growing problem, and the negative consequences associated
with SUD impact people across all age groups; therefore, understanding more about
differences and similarities in substance abuse behaviors across age groups, as well as
patterns within and between age groups in terms of race and gender differences, may
provide useful information for future research and clinical work. Therefore, an additional
aim of this study is to examine and describe potential differences in substance abuse
problems across age cohorts.
Prevalence and Trends of Substance Abuse and Dependence
Recent reports from the 2018 National Survey on Drug Use and Health
(NSDUH), a population-based survey used to assess substance use trends among noninstitutionalized U.S. citizens that are 12-years-old or older, showed that approximately
20.3 million survey respondents endorsed past-year abuse of alcohol (14.8 million
people, with approximately 11.0 million reporting an alcohol use disorder in the past
2

year) or an illicit drug (8.1 million people). Past year substance abuse is currently greatest
for cannabis use (4.4 million people), followed by prescription pain relievers (1.7 million
people) or heroin (0.5 million people). Although the percentage of people with any SUD
in 2018 was similar to rates in 2015 to 2017, the percentages of people with alcohol use
disorder, pain reliever use disorder, or opioid use disorder were lower than in 2015
(NSDUH, 2018). Lipari, Ahrnsbrak, Pemberton, and Porter (2017), explored the
implications of perceptions of health risks associated with abuse of different substances
including cannabis, cocaine, alcohol, and cigarettes across age groups. They found that
across age groups, individuals who perceive a given substance as having low health risk
were more likely to develop a SUD with that substance than individuals who perceive the
substance as having high health risk. One concern highlighted in this report, is that
although perception of risk was high (four out of five people aged 12 or older) for
cocaine, heroin, or lysergic acid diethylamide (LSD), the perception of risk for cannabis
use was significantly lower (i.e., approximately one third of the sample perceived weekly
cannabis use as causing great risk of harm). This perception of low risk associated with
weekly cannabis use varied across age groups, with the young adults (ages 18 to 25)
being the group that reported the lowest perception of risk of harm from weekly cannabis
use (Lipari et al., 2017). It is important to note that the data derived from the NSDUH
does not include data from people with no fixed address (e.g., homeless people not in
shelters, military personnel on active duty, and institutionalized individuals such as those
in jails, nursing homes, mental institutions, and long-term care hospitals) (Lipari et al.,
2017). Overall, trends from SUD statistics derived from data from both the United States
and globally, show that while alcohol abuse and dependence remains the most prevalent
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SUD worldwide, alcohol abuse problems have decreased overall (Seitz et al., 2019).
Problems with abuse and dependence of most substances, including alcohol, cocaine,
hallucinogens, heroin, and prescription drugs have remained relatively constant over the
past decade (Lipari et al., 2017; Lipari & Van Horn, 2017; Seitz et al., 2019). However,
the rates of cannabis abuse continue to increase in the U.S. and in European countries
(Lipari & Van Horn, 2017; Seitz et al., 2019), as perceptions of the risk of harm from
cannabis use continue to decrease over time (Lipari et al., 2017). The risks associated
with the low perception of harm continue to rise the most in youth populations (Lipari et
al., 2017; Seitz et al., 2019).
Benefits and Limitations of Commonly Administered SUD Screening Tools
Although reports continue to indicate a great need for detection and treatment of
substance abuse problems, few adults are asked about alcohol or drug abuse problems in
primary health care settings (Pilowsky & Wu, 2012). This is likely since standardized
diagnostic interviews can take hours to administer and are typically concerned with
highly specific diagnostic criteria at the expense of sensitivity in detection of problems
(Carey, 2002). Therefore, the use of psychometrically sound, efficient, screening tools is
a necessity for the detection of problems in clinical settings, particularly in the context of
mental health care (Carey, 2002). Brief screening tools are clinically useful given that
treatment services at many clinical sites are fast paced, with high patient volume in
relation to the number of clinical staff (Pilowsky & Wu, 2012). These efficient
assessment tools can be used to quickly detect problems which warrant further
investigation. Screening tools that are commonly used in busy medical settings, such as
the Dartmouth Assessment of Lifestyle Instrument (DALI), the Drug Abuse Screening
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Test (DAST), the Alcohol Use Disorder Identification Test (AUDIT), Michigan
Alcoholism Screening Test-Revised (MAST), and CAGE questionnaire, are useful in
detecting drug or alcohol problems (Hays, Merz, & Nicholas, 1995; Rosenberg et al.,
1998; Reinert 2002; Shields, Howell, Potter, & Weiss, 2007; Skinner, 1982; Yudko,
Lozhkina, & Fouts, 2007). However, these screening tools have several limitations. For
example, these measures are limited in that they assess for either drugs (i.e., the DALI
and DAST) or alcohol (i.e., the AUDIT, MAST, and CAGE), and epidemiological
evidence suggests that it may be important to assess patients for both alcohol and drug
problems (Pilowsky & Wu, 2012; Schuckit, 2006). The World Health Organization
addressed this issue by developing a more comprehensive substance abuse screening tool
for busy primary care settings, the Alcohol, Smoking, and Substance Involvement
Screening Test (ASSIST) (Humeniuk et al., 2008). In comparison to similar screening
tools the ASSIST includes more descriptive items and response options (i.e., scaled
ratings) inquiring about substance abuse problems experienced within a shorter time
frame than similar measures (i.e., three months). There is evidence that these features
greatly improve the sensitivity and specificity in detection of substance abuse problems
(Humeniuk et al., 2008). Although the ASSIST appears to be an improvement on the
screening tools discussed above, it can be argued that a three-month time frame is too
broad for accurate assessment of current problems. This is particularly limiting in the
context of mental health treatment, given that psychotherapy typically requires more
current information for weekly treatment planning and tracking of progress. Therefore, a
measure which assesses problems experienced within the past two weeks has the
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potential to significantly improve on the currently available substance use disorder (SUD)
screening tools.
Consideration of SUD Age Differences
While reports show that SUD is a prevalent issue in younger age groups
(Johnston, O'Malley, Bachman, Schulenberg, & Miech, 2014), trends indicate that there
is also a growing need for substance abuse interventions in the U.S. old adult population
(Arndt, Clayton, & Schultz, 2011). Although research findings suggest that drug and
alcohol abuse is a declining issue in older populations, these results may be misleading.
For example, while rates of treatment admissions for primary use of alcohol only have
decreased between 1990 and 2010, rates of primary use of illicit drugs and misuse of
prescription drugs have increased in older adults (Wu & Blazer, 2011). A comparison of
age cohorts of persons 50 to 64 years of age and persons 65 years of age and older,
reveals that the shifting trends in the types of substances abused is related to an
increasingly high rate of illicit drug use and nonmedical use of prescriptions in the 50 to
64 years of age cohort (Wu & Blazer, 2011). Lifetime prevalence rates assessed in the
Monitoring the Future survey appear to coincide with these findings. Eighty-eight percent
of 50-year-olds reported trying an illicit drug, which is much higher than reports from
previous 50-year-old cohorts as well as reports from current U.S. adults aged 29 to 30
(Johnston et al., 2014). This high rate of lifetime prevalence is largely attributed to the
fact that current 60 to 70-year-olds passed through adolescence near the peak of a U.S.
drug epidemic (i.e., 1970s-80s) (Johnston et al., 2014). It is also important to note that
while annual incident rates of substance abuse (i.e., past-year SUD) tend to decline over
the course of one’s lifespan (Johnston et al., 2014), the issue of current misuse and abuse
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of prescription drugs appears to be increasing the most in women age 50 and older
(Wastila & Yang, 2006). Given the strong association between substance use problems
and comorbid mood and anxiety disorders (Compton, Thomas, Stinson, and Grant, 2007;
Kessler, Chiu, Demler, & Walters, 2005), higher rates of self-reported mood and anxiety
disorders in older women compared to older men (Byers, Yaffe, Covinsky, Friedman, &
Bruce, 2010) may be related to the observed increase in substance use problems in older
women. Overall, the current literature has identified female gender, social isolation,
depression, and a history of substance abuse as factors that are strongly associated with
increased risk for misuse and abuse of prescription drugs in geriatric populations
(Culberson & Ziska, 2008). The generational context, during a time in which current
“baby-boomers” were adolescents and young adults, is implicated as a key reason for this
expected shift in substance abuse trends (Johnston et al., 2014). More specifically, in
comparison to their older counterparts, the “baby-boomer” generation was exposed to the
U.S. 1970-80s drug epidemic during a developmental period in which they were most
vulnerable for developing chronic SUD and associated issues throughout adulthood
(Johnston et al., 2014). A social change that may contribute to the rising concern of SUD
in older populations is increased prescribing of opioid-based medications, which are
highly addictive and potentially dangerous pain remedies (Preda, 2015; Simoni-Wastila
& Yang, 2006).
Regarding differences in prevalence rates of the types of substances abused across
age cohorts, abuse of psychostimulants appears to be more prevalent in younger age
groups (Kaye & Darke, 2012; Kroutil et al., 2005), whereas the association between age
and opioid abuse appears to be less clear. More specifically, although there is some
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evidence of an inverse relationship between age and a diagnosis of opioid
abuse/dependence which indicates that older persons tend to abuse opioids less than
younger persons (Edlund et al., 2010), more recent evidence shows that opioid abuse and
associated comorbidities tend to increase exponentially with age (Cicero et al., 2012).
This suggests that although abuse of opioids may be more prevalent in younger age
groups, the negative impacts associated with abuse of these agents are much more severe
in older age groups. In addition, it is oftentimes more difficult to assess substance abuse
problems in patients who have undergone long-term opioid therapy (Edlund et al., 2010).
This problem is a particular concern in older persons because, in comparison to younger
age groups, they are less likely to perceive substance abuse as a problem that requires
treatment (Wu & Blazer, 2011). This literature highlights the nuanced nature of the
current state of drug misuse and abuse in the U.S., and the need for future research that
considers the complexity of individual factors that may contribute to one’s substance
abuse problems.
Relationships Between Behavioral Dysfunction and SUD
It is important to consider the complex mechanisms underlying the relationships
between SUD and associated risk factors, as it is well established that psychiatric issues
are prevalent among SUD populations (Kessler et al., 2005). There is some evidence that
neuroadaptations in stress and reward pathways, as a consequence of the childhood
behavioral problems (i.e., depression, post-traumatic stress disorder, and ADHD), may
predispose individuals to abuse substances as they grow into adolescence and adulthood
(Brady & Sinha, 2005). Childhood events such as sexual and physical trauma as well as
the negative social consequences associated with externalizing behaviors of ADHD have
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been implicated as key issues that typically precede and confound the neuroadaptations
that increase one’s risk for a SUD (Brady & Sinha, 2005).
It is well established that there are strong relationships between deliberate selfharm (i.e., intentionally injuring oneself without suicidal intent) and mood disorders such
as anxiety and depression (Klonsky, Oltmanns, & Turkheimer, 2003). Of note, these
relationships were found in a sub-clinical, general population. Therefore, these
associations can be generalized to those outside of the more severe presentations of selfharm which are typically found in psychiatric populations (Skegg, 2005). Additionally,
evidence examining relationships between self-harm and SUD indicates that injurious
behaviors appear to both precede, as well as begin or worsen with abuse of certain
substances, such as psychostimulants (Muehlmann & Devine, 2008). The underlying
mechanism associated with the complex interactions between deliberate self-harm and
SUD appears to be emotional and behavioral dysregulation (Gratz & Tull, 2009).
Moreover, deliberate self-harm behaviors and comorbid mood disorders (i.e., anxiety and
depression) appear to be a particularly significant issue in women with childhood sexual
abuse histories (Gladstone et al., 2004). Mood disturbances appear to have similar
interactions with SUD, in that mental health disorders can lead to greater risk of
substance abuse, or conversely, substance abuse can trigger or worsen psychiatric
symptoms (Brady & Lyniard, 1992; Center for Substance Abuse Treatment, 2005;
Quello, Brady, & Sonne, 2005; Schuckit, 2006). Overall, the presently discussed risk
factors play complex, interactive roles in the progression of emotional and behavioral
problems and associated substance abuse/dependence. Therefore, relationships between
self-reports on assessments of respective SUD risk factors (e.g., depression and anxiety,
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childhood trauma, ADHD, and deliberate self-harm) and the proposed CUSAPOS
subscales will be used to examine convergent and divergent associations in order to
clarify construct validity. Pearson correlations that indicate positive relationships (i.e.,
convergence) between self-reports on SUD risk factors and the CUSAPOS subscales will
support the assumption that CUSAPOS items are accurately describing alcohol and drug
abuse problems, respectively.
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Analytic Plan and Hypotheses
Exploration of Substance Abuse Problems Across Age Cohorts.
The initial sample (N = 1620) of outpatient psychiatric patients that completed
SCID interviews as part of the MIDAS project, were compared based on self-reported
past-year substance abuse problems. After testing statistical assumptions, analyses
described substance abuse patterns amongst the different age cohorts. Respective
substance abuse severity ratings from the SCID interviews were dichotomized in order to
differentiate between lifetime (i.e., ratings of one or two coded as 0) and past-year (i.e.,
ratings of three and greater coded as 1) substance abuse/dependence. Chi-square (χ2) tests
will be used to compare the prevalence of past-year substance abuse/dependence of
respective drug types (i.e., sedative-hypnotic-anxiolytics, cannabis, stimulants, opioids,
cocaine, and hallucinogens), between different age groups.
Principal Components Analyses and Confirmatory Measurement Development of
the CUSAPOS Subscales
A subsample of 727 participants who reported past year substance abuse, were
randomly split into two separate groups in order to be used in principal components
analysis (PCA) (N = 150) and confirmatory factor analysis (CFA) (N = 577) for
measurement development of the CUSAPOS subscales. The final factor structure was
established based on fit indices including the comparative fit index (CFI), Tucker Lewis
Index, the standardized root mean square residual (SRMR), and the root mean square
error of approximation (RMSEA).
A subsample of 624 participants who endorsed at least one substance abuse
problem on either CUSAPOS subscale were included in multigroup comparisons
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examining variables that may confound the relationships between age and alcohol
problems, or age and drug problems. ANOVAs assessing mean differences between the
four Age Cohorts and each of the two CUSAPOS subscales were run before proceeding
to examining other group differences, based on participant self-report on other measures
that assess for potential SUD risk factors, as well as demographic characteristics. The
Age Cohort groups have unequal sample sizes, therefore, the Dunnett C test was used for
follow-up analyses on significant relationships between Age Cohorts and the CUSAPOS
subscales.
To compare alcohol and drug abuse problems amongst different age groups, a
series of analyses of covariance (ANCOVAs) were run with covariates, including the
summed total scores of the self-report scales assessing for ADHD (ASRS), Childhood
Trauma (CTQ), and Self-Injury (SIQ), which may influence the relationships between the
categorical independent variable, Age Cohort, and continuous DVs, the proposed
CUSAPOS measure. Two-way ANOVAs were conducted to examine the potential effect
that confounding variables, including Race, Gender, and Mood Impairment may have on
the mean differences in scores on each respective scale between Age Cohorts.
Hypothesis I
It is predicted that the descriptive crosstabulations will show significant group
Chi-square differences in the types of drugs participants reported abusing in the past year
(N =1,620) between Age Cohorts. Based on previous literature, it is expected that older
age groups (i.e., Middle Age and Older Adults) will struggle with substances that may
partially reflect problems with prescription drug abuse, such as
sedatives/hypnotics/anxiolytics and opioids.
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Hypothesis II
The internal consistency of items is expected to be adequate in both of the
CUSAPOS subscales. A series of PCAs will detect any items that appear redundant and
should therefore be eliminated from the measure. The two respective CUSAPOS subscale
scores will be significantly correlated with scores on the measures that assess SUD risk
factors, including those that assess for Childhood Trauma (CTQ), Self-Injury (SIQ), and
ADHD symptoms (ASRS). Examination of factor structure is expected to show evidence
for two distinct subscales that assess for alcohol and drug abuse problems, respectively.
Hypothesis III
It is expected that mean scores on the respective CUSAPOS subscales will vary
significantly between age groups, specifically between younger and older age cohorts
(i.e., Young Adult and Adult groups compared to Middle Age and Older Adults groups),
due to generational differences. In addition, given that previous research indicates that
factors such as race, gender, mental health problems, childhood trauma, ADHD, and SelfInjury may influence the severity of SUD problems across age groups, it is expected that
the present study’s ANCOVAs and two-way ANOVAs will reveal the influence that
confounding variables including Race, Gender, Mood Impairment, ADHD, Childhood
Trauma, and Self-Injury, may have on the mean differences in the respective CUSAPOS
subscale scores, between Age Cohorts. However, as discussed above, the anticipated
nature of these findings is unclear.
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Methods
Participants and Procedures
The present study utilized cross-sectional data from an ongoing study, Methods to
Improve Diagnostic Assessment and Services (MIDAS) at Rhode Island Hospital (PI:
Mark Zimmerman, MD). Data were gathered from psychiatric outpatients seeking
treatment at the Outpatient Psychiatry Practice of Rhode Island Hospital (RIH)
(Dalrymple et al., 2013). Participants were excluded from the MIDAS study if they had
difficulties communicating in the English language or had a history of developmental
disabilities (Zimmerman et al., 2014). Of note, all participants were insured (i.e., not on
Medicaid) and mental health treatment seeking. Participants underwent a clinicianadministered Structured Clinical Interview for DSM Disorders (SCID), which provides
supplemental details of participants’ presentation of symptoms (Zimmerman, Morgan,
Dalrymple, Young, and Chelminski, 2014). Trained SCID diagnostic interviewers rated
patients’ SUD severity upon intake, with single-item severity ratings ranging from 1
(least severe) to 8 (most severe) for respective drug classes including sedative-hypnoticanxiolytics, cannabis, stimulants, opioids, cocaine, and hallucinogens. Participants (N =
1,620) who reported abusing substances at some point in their lifetime were included in
the sample used to evaluate the prevalence of SUD by different age groups. For the
purpose of these exploratory analyses, participant ratings were dichotomized to
differentiate between lifetime and past-year substance abuse/dependence. Data assessing
mood disorders and the severity of mood impairment were also derived from participants’
responses on the SCID.
In addition to these interviews, participants were also asked to complete a selfadministered questionnaire packet that includes measures assessing for the SUD risk
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factors discussed above as well as the CUSAPOS subscales. Of the MIDAS study
participants who completed the CUSAPOS items, only 727 participants that reported any
alcohol or drug problems are included in the PCAs (N = 150) and CFAs (N = 577) of the
CUAPOS and the CUDPOS. Demographics were assessed with single item measures.
The demographic items of interest for the present analyses include age (i.e., age groups of
18-25, 26-35, 36-49, 50 and older), gender (i.e., female or male), and race/ethnicity (i.e.,
White, Black, Hispanic, Asian, Portuguese, Other, Native Hawaiian/ Other Pacific
Islander, American Indian/Alaskan Native). The participants’ ages range from 18 to 84years-old. Approximately 25% are aged 18 to 25, 20% are aged 26 to 34, 33% are aged
35 to 49, 22% are aged 50 and older. The prevalence of females (53%) in this sample is
similar to males (47%). In terms of race/ethnicity, the majority of the sample is White
(88%), with Black being the second most prevalent racial group (4.8%). A small portion
of the sample reported Hispanic (2.3%), Asian (1.4%), or Portuguese (2.2%)
races/ethnicities.
Data from the age variable were recoded using SPSS version 26 software (IBM
Corp, 2019), and grouped into four distinct age categories: Young Adult (coded as 0),
Adult (coded as 1), Middle Age (coded as 2), and Old Adult (coded as 3). The Race
variable was also recoded due to an inadequate sample size (N < 50) for the present
analyses in the Black (N = 33), Hispanic (N = 14), Asian (N = 10), Portuguese (N = 14),
and Other (N=5) racial groups, with no participants endorsing the Native Hawaiian/ Other
Pacific Islander, or American Indian/Alaskan Native categories. These race groups were
recategorized into two groups labeled as ‘Persons of Color’ (N =76) and ‘White’
(N = 548).
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Measures
Substance Abuse Problems and Severity Measures
Clinically Useful Substance Abuse Problems Outcomes Scales (CUSAPOS)
The proposed screening tool, CUSAPOS, was derived mainly from the DSM-IV
and two 15-item potential subscales were developed to better understand the severity of
problems associated with alcohol and drug abuse, respectively. Of note, these two item
sets cannot be considered as respective alcohol and drug abuse subscales until analyses
for measurement development, as described below, confirm the validity and factor
structure of the total 15 items in each scale. The items are self-administered and the
instructions prompt participants to reflect on substance abuse problems experienced
within the past two weeks. Items are rated on a 5-point Likert scale, ranging from 0 (‘Not
at all true’) to 4 (‘Almost always true’). Higher ratings, which are derived from the total
score for each subscale, indicate more problems with abuse of alcohol and drugs,
respectively.
Substance Abuse Severity Ratings
The Structured Clinical Interview for DSM-IV Disorders (SCID) is an extensive
diagnostic tool that has shown reliability and validity across many different groups (First,
Spitzer, Gibbon, & Williams, 2012). The severity of substance abuse behaviors across
respective classes of drugs including sedative-hypnotic-anxiolytics, cannabis, stimulants,
opioids, cocaine, and hallucinogens is measured with one-item ratings within the SCID.
These items were clinician-administered, and participants were asked to clarify the
specific substance(s) they struggle with and rate their self-perceived severity of abuse of
respective substances on an 8-point Likert scale, with higher ratings indicating greater
severity. Given that one-year of sobriety has consistently been shown to be one of the
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most clinically significant indicators for life-long sobriety, significantly improved
cognitive functioning, and improved overall satisfaction with life (Hagan et al., 2017),
ratings were dichotomized to differentiate participants between two groups: lifetime
substance abuse/dependence, and past-year substance abuse/dependence.
SUD Risk Factor Assessments
Mood Impairment
The Mood Disorders and Anxiety Disorders subscales of the Structured Clinical
Interview for DSM Disorders (SCID) were used to assess for depression and anxiety
symptoms. Trained interviewers rated each symptom based on patient responses on a 3point scale with 1 indicating ‘absent or false’, 2 indicating ‘subthreshold’, and 3
indicating ‘threshold or true.’ Some sections include additional ratings: 4 which indicates
the symptom ‘may be better accounted for by a general medical condition (GMC),’ 5
indicates the symptom is ‘definitely better accounted for by a GMC,’ and 6 indicates
‘baseline.’ SCID raters indicated that the patient reported inadequate information for
appropriate rating of an item with ‘?’. Although the SCID that was utilized in this study
is based on DSM-IV classification of disorders, interpretations were modified for the
present study in order to reflect any DSM-5 revisions (Zimmerman et al., 2014).
Interviewers used the SCID to assess whether participants meet criteria for several
different mood disorders, and they also assessed the level of mood impairment with
scores summed into a categorical variable that indicates whether the participant meets
criteria for severe mood impairment (coded as 1) or do not meet criteria for severe mood
impairment (coded as 0). The present study is interested in examining the cognitive and
behavioral problems or negative consequences attributed to substance abuse, therefore,
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instead of using the variable that indicates whether participants meet criteria for a given
DSM-IV disorder, the Mood Impairment variable was evaluated as a categorical
independent variable (IV) in the present study.
Adult ADHD Self-Report Scale (ASRS), Symptom Checklist
The ASRS, Symptom Checklist (Kessler et al., 2005), is a self-report measure
that includes 18 items describing problems caused by inattentive and hyperactive
symptoms associated with ADHD (e.g., “How often do you interrupt others when they
are busy?”). Participants reported the severity of these problems, within the past six
months, by endorsing ratings ranging from ‘Never’ to ‘Very Often.’ A sum of the total
item responses was used to indicate the severity of interfering symptoms caused by
ADHD. Psychometric evaluation of this measure revealed it is useful in assessing for
ADHD in SUD populations (Daigre et al., 2009). Participants’ summed scores on the
ASRS were used to examine the effect ADHD symptoms may have on the relationships
between age and alcohol or drug abuse problems. Appendix A shows the full list of
ASRS items and ratings.
Childhood Trauma Questionnaire (CTQ)
The CTQ is a self-report measure that includes 53 items that inquire about sexual
and physical abuse and neglect, family relationships/emotional support, and parenting
behaviors (Bernstein, Fink, Handelsman, & Foote, 1994). Items reflect scenarios that
describe both abusive and healthy family relationships, and the items that reflect
protective factors were reverse scored (e.g., “There was someone in my family whom I
admired and wanted to be like”). Participants are asked to rate each item on a 5-point
Likert scale with 1 representing ‘Never true’ to 5 representing ‘Very often true.’ Higher
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summed scores indicate greater severity of childhood trauma (Gaudiano & Zimmerman,
2010). Participants’ summed scores on the CTQ were used to examine the effect a
history of childhood trauma may have on the relationships between age and alcohol or
drug abuse problems. Appendix B shows the complete list of CTQ items and ratings.
Self-Injury Questionnaire (SIQ)
The SIQ is a 13-item, self-report measure, that assesses whether an individual had
deliberately injured him/herself by cutting, burning, picking, hitting, or scratching
themselves in the past three months. Items were derived from the Inventory of Statements
About Self-Injury (ISAS), which assesses for 13 functions of non-suicidal self-injury
(Klonsky & Glenn, 2009). Participants reported how often they engaged in these
behaviors, within the past three months, on a 4-point scale, from 0 ‘Never,’ to 3 ‘Three or
more times.’ Higher scores indicate greater severity of deliberate self-harm behaviors.
Total scores showing more severe deliberate self-harm behaviors typically indicate higher
risk for other forms of behavioral dysregulation as well as suicidal thoughts and
behaviors (Santa Mina et al., 2006). Appendix C shows the complete list of SIQ items
and ratings.
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Results
Substance Abuse Across Age Groups
In order to describe the rates of abuse and dependence of different classes of
drugs (i.e., sedatives/hypnotics/anxiolytics, cannabis, stimulants, opioids, cocaine, and
hallucinogens) amongst different age cohorts (i.e., 18-25, 26-35, 36-49 and 50+ yearsold), crosstabulations were conducted on a sample of participants who endorsed having
abused substances at some point in their lifetime (N = 1,620). Substance abuse and
dependence severity ratings, ranging from 1 (least severe) to 8 (most severe) were
assessed by an interviewer who was trained in administration and scoring of the
Structured Clinical Interview for DSM IV Disorders (SCID). For the purpose of the
present analyses, ratings were dichotomized to differentiate between lifetime (N = 893)
and past-year substance abuse/dependence (N = 727).
Chi-square tests for independence were used to examine age group differences in
drugs abused in the past year. Results revealed significant associations between age and
sedative/hypnotics/anxiolytics, χ2 (3, N = 1620) = 19.85, p <.001, cannabis, χ2 (3, N =
1620) = 23.85, p < .001, stimulants, χ2 (3, N = 1620) = 36.03, p <.001; and cocaine use in
the past year, χ2 (3, N = 1620) = 32.37, p < .001. No significant age differences were
found in opioid abuse and dependence, χ2 (3, N = 1620) = 1.26, p = .74, and
hallucinogens, χ2 (3, N = 1620) = 3.22, p = .36, and follow-up analyses revealed similar
severity ratings across Age Cohorts. Cannabis abuse was the most prevalent across all the
age groups (Young Adult = 21.2%, Adult = 23.5%, Middle Age = 30.5%, and Old Adults
= 13.5, compared to all other substances included in the analyses. Overall, the 36-49
years-old cohort reported greater past-year abuse of sedatives/hypnotics/anxiolytics
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(6.5%), cannabis (30.4%), stimulants (7.3%), opioids (6.1%) and cocaine (13.1%)
compared to the other age groups. Table 1 presents detailed information on the rates of
past year abuse of different drug types, within four age groups (i.e., ages 18 to 25, ages
26 to 35, ages 36 to 49, and ages 50 and older).
Principal Components Analyses Results
To examine the factor structure of the proposed CUSAPOS measure, the 30 item
responses were factor analyzed using PCA with promax (oblique) rotation, using SPSS
software version 26 (IBM corp., 2019) on a subsample that was extracted from the total
727 participants (N = 150). Table 2 shows demographic information, including gender
and race, by Age Cohort, from the 727 participants included in the measurement
development analyses. Table 3 shows the demographic information for the subsample
used for the PCAs, exploring the factor structure of the initial proposed 30 items.
It was hypothesized that the 30-item response set in the proposed CUSAPOS
would show a two-factor structure for alcohol and drug problems, respectively; however,
PCA results showed that less than half of the variance that can be explained by a twofactor structure for alcohol (35.92%) or drug problems (23.57%). In addition, results from
PCAs exploring the initial factor structure of the complete set of 30 proposed items
revealed that items loaded onto two distinct factors, with the first 15-item set appearing to
assessing for alcohol problems, and the latter 15 for drug problems. Table 4 shows the 30
items and their factor loadings from the exploratory PCA results. The KMO result
assessing the overall fit of the total 30 items (.882) shows slightly weaker fit than the
respective Clinically Useful Alcohol Problems Scale (CUAPOS) (.991) and the Clinically
Useful Drug Problems Scale (CUDPOS) (.898), with the Barlette’s Test of Sphericity
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showing a significant chi-square test result, which indicates good overall fit for each scale
(Krishnan, 2010). Overall, these results suggest that the items should be separated into
two respective scales, separately assessing for alcohol and drug problems. To better
understand the factor structure of each scale, two separate PCAs with a Promax (oblique)
rotation, and two fixed factors, were conducted with the item response sets from each
respective scale.
CUAPOS Development
The initial PCA results for the 15 items assessing for alcohol abuse problems show a twofactor structure with Factor 1 explaining 51.91% of the total variance. Upon further
examination of the items in the CUAPOS, it appears that the items loading on Factor 1
assess for self-awareness or insight regarding alcohol problems (e.g., I thought that my
drinking was a problem), whereas items loading on Factor 2 assess for alcohol abuse
behaviors (e.g., I had more than 3 drinks of alcohol in a day). A correlation matrix was
used to identify items that highly correlate (i.e., redundant items) in each respective scale.
Items that highly correlated with multiple items were deleted. In addition to identifying
correlated items for item reduction, weaker loadings (i.e., ≥ .40) and cross-loadings were
used as an indicator to extract additional items, including item 71 (i.e., “I couldn’t stop
drinking when I wanted to”). After several iterations of item response sets were analyzed,
PCA results showed that the best fit for the CUAPOS is a two-factor model with a total
of nine items. After identifying the factor structure of this scale, the goodness of fit of this
model was then confirmed with a CFA on the overall sample.
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CUDPOS Development
The 15 items assessing for drug abuse problems were also factor analyzed using PCA
with a Promax (oblique) rotation. Consistent with the CUAPOS factor structure, Factor 1
in the CUDPOS appears to describe insight on one’s own drug abuse problems and it
explains 65.79% of the total variance, whereas Factor 2 appears to assess for the
behavioral problems associated with drug abuse and dependence. Highly correlated
items, and items with low factor loadings or cross-loadings, were evaluated for the
extraction of complicated items such as item 87 (i.e., “I had a strong urge to use drugs”)
in the CUDPOS scale. The PCA results exploring different iterations of item response
sets, indicated that the best fit for the CUDPOS is a two-factor model with a total of eight
items. This factor structure was confirmed with CFAs examining the overall model fit, as
discussed below. Table 5 shows the mean (M) and standard deviation (SD), as well as the
factor loading for each item included in the confirmed factor structure for both the
CUAPOS and the CUDPOS.
Confirmatory Factor Analysis Results
The statistics program, R, was used to perform CFAs on the remaining 577
participants, to evaluate the goodness of fit of each model (i.e., the CUAPOS and the
CUDPOS) across four different age cohorts: Young Adults (N = 152), Adults (N = 132),
Middle Age (N = 201), and Old Adults (N = 139). Before running CFAs on the CUAPOS
and the CUDAPS, respectively, exploratory analyses confirmed that statistical
assumptions such as normality, linearity, and homoscedasticity were met for the
distribution of scores across age cohorts, for both scales. In addition, the large size of the
total sample (N = 577) is adequate to properly establish model fit (Fischer & Karl, 2019).
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Chi-square tests are not a reliable indicator for the present analyses, given that the large
sample size creates a significant chi-square result, artificially rejecting the model (Fischer
& Karl, 2019). Therefore, each two-factor model was evaluated for goodness of fit based
on four alternative fit indices including the CFI, TLI, SRMR, and the RMSEA (Cook,
Kallen, & Amtmann, 2009; Xia & Yang, 2018). A CFI and TLI value of .95 or higher
indicates good model fit, and in contrast, lower values (ideally between .06 to .08) for the
lack of fit indices, RMSEA and SRMR, indicate better model fit (Fischer & Karl, 2019).
The two-factor solution for the CUAPOS showed good model fit across indices (CFI =
.997, TLI = .995, SRMR = .046, RMSEA = .064), as well as the CUDPOS (CFI = 0.972,
TLI = .958, SRMR = 0.031, RMSEA = 0.081). Both the CUAPOS and CUDPOS showed
good fit for each respective age cohort. Table 6 shows detailed information on the
goodness of fit indices by age cohort, for both the CUAPOS and the CUDPOS.
Multigroup Confirmatory Factor Analyses for the CUAPOS
To examine whether the CUAPOS has the same measurement properties across
the four age cohorts (i.e., Young Adults, Adults, Middle Age, and Old Adults) multigroup CFA was the statistical method employed. In a hierarchical fashion, CFAs were
performed with different levels of parameter constraints, in order to test the level of
invariance across age cohorts (Fischer & Karl, 2019) For the first step, a CFA analyzed
form invariance, or configural invariance to examine the overall fit, with the theoretical
assumption that the items were loaded on the same latent factor with no parameter
constraints, in the CUAPOS. The fit indices for the configural invariance of the CUAPOS
show results that are below the typical cut-off levels for good model fit across all indices
(CFI = .914, TLI = .898, SRMR = .054, RMSEA = .128), however, these results show
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adequate model fit when the large total sample size (N = 577) is considered (e.g., CFI ≥
.901, Shi et al. 2019). The second level to invariance testing is factorial, or metric
invariance, which constrains factor loadings to be equal across age groups. This test
reveals any non-uniform item bias amongst the different age cohorts (Fischer & Karl,
2019). Compared to the configural invariance results, metric invariance results show
poorer model fit across indices (CFI = .898, TLI = .883, SRMR= .088, RMSEA = .127).
Given the relatively poor fit of the model at the metric invariance level, invariance testing
did not proceed to comparisons of models with more parameter constraints. An Analyses
of Variance (ANOVA) compared the chi-square test statistics between the first,
configural model, and the second, factorial model: !2 (21) 66.86, p = .001. A significant
chi-square difference test result (p ≥ .05) would indicate that responses on the CUAPOS
are theoretically equivalent across age groups, meaning that the scale items assess for the
same latent constructs, in a similar manner across age cohorts (Fischer & Karl, 2019).
Therefore, the significant chi-square difference test result between the two models (i.e.,
configural invariance and metric invariance) for the CUAPOS, indicates that the model
does not show adequate invariance to assume that the scale items equivalently assess for
the same latent factors, in a similar manner across the four age cohorts.
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Multigroup Confirmatory Factor Analysis for the CUDAPS
A series of CFAs were performed to assess the level of invariance with different
parameter constraints. With no parameter constraints, the CFI and the SRMR indicate
adequate goodness of fit for the configural invariance model (CFI = .913, TLI = .872,
SRMR = .05, RMSEA = .153). As previously mentioned, the lower than desired TLI
statistic as well the higher than desired RMSEA, may be influenced by the large total
sample size (Shi et al., 2019). The second step, a CFA constraining the factor loadings to
be equal for metric invariance testing, showed adequate fit across all indices (CFI = .90,
TLI =.881, SRMR = .094, RMSEA = .148). Therefore, like the CUAPOS, invariance
testing did not continue to show good model fit with added constraints (i.e., scalar
Invariance, and strict invariance). An ANOVA compared the CFA results between the
first (configural invariance) and second (metric invariance) models and showed a
significant chi-square difference test result. This indicates that the CUDPOS is noninvariant amongst age cohorts, and it cannot be assumed that the items reflect the same
latent factors similarly across age groups. Table 7 shows results from the invariance
testing on both the CUAPOS and the CUDPOS.
Descriptive Statistics for Demographic Characteristics and SUD Risk Factors
In order to reduce skew in participants’ responses to items on the CUAPOS and
the CUDPOS, the cases that did not endorse any substance abuse problems (i.e.,
participants who reported a total score of zero on both scales) were eliminated. Only the
participants who endorsed at least one substance abuse problem on either the CUAPOS
or the CUDPOS were included in the analysis of variables that may confound the mean
differences in participant scores on each respective scale, between age groups (N = 624).
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Correlations were used to describe the linear relationships between the scales used
in the present study, which include the CUAPOS (N = 624, M = 6.63, SD =7.40), the
CUDPOS (N = 624, M = 3.2404, SD = 6.15), the ASRS (N = 326, M = 35.39, SD =
12.67) the SIQ (N = 515, M = 2.04, SD = 3.56) and the CTQ (N = 544, M = 106.78, SD =
45.88), on the subsample of participants who endorsed at least one substance abuse
problem on either the CUAPOS and the CUDPOS. Table 8 shows the descriptive
statistics for each scale and the correlations of mean scores between the scales across the
four age groups (Young Adults, Adults, Middle Age, and Older Adults). A weak, yet
statistically significant positive correlation was found between the CUDPOS and the SIQ
(r (515) = .09, p < .05), meaning that as self-reported problems related to drug abuse
problems increase, self-injurious behaviors may be likely to increase as well. The ASRS
showed a significant positive correlation with the CUDPOS (r (326) = .15, p < .01),
meaning that as participants reported more ADHD symptoms, they also reported more
drug abuse problems. The CUDPOS also showed a weak, but significant inverse
relationship with the CTQ (r (515) = -.09, p < .05), which indicates that as participants
reported less childhood trauma, they also reported less drug abuse. The SIQ also showed
a positive correlation to the ASRS (r (326) = .26, p < .01), indicating that higher levels of
ADHD symptoms may be related to more severe levels of self-injury. Of note, the
CUAPOS and the CUDPOS were orthogonal, with a correlation close to a zero (r (624) =
.02, p > .05). This result is consistent with the PCA results previously described, which
suggest that the proposed CUSAPOS measure should be treated as two conceptually
distinct scales. Table 7 shows the correlations between the scales included in the present
study.
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Demographic Characteristics on Participants Who Self-Reported Substance Abuse
Problems in the Past Week
To describe the categorical groups examined in the present analyses,
crosstabulations compared gender, race, and mood impairment by Age Cohort, in a
subsample of participants who reported experiencing at least one substance abuse
problem in the past week. Results show that percentages for female (51.6%) and for men
(48.4%) were similar to the larger sample of 727 of participants who reported having
abused a substance in the past year; however, the larger sample shows more of a
percentage difference between females (53.0%) and males (47.0%). Similar to the larger
sample of 727, the smaller sample of past week substance abusers have a similar
percentage of White participants (87.8%), with only 4.8 percent representing Persons of
Color. Table 9 shows a detailed description of this subsample’s demographic
characteristics, as well as the significant mood impairment, by Age Cohort.
After the best fitting models for both the CUAPOS and the CUDPOS were found
using CFAs (N = 577), the sample used for CFAs was merged with the sample used for
the initial PCAs (N = 150), to return to the total number of participants in the present
study (N = 727). A subsample that includes the data from the CUAPOS and the CUDPOS
together with data derived from continuous and dichotomous measures that assess several
substance abuse risk factors as well as demographic characteristics including: Gender
(i.e., Female or Male), Race (i.e., White or Person of Color), the Adult ADHD Self-report
Scale, Symptom Checklist (ASRS), the Self-Injury Questionnaire (SIQ), the Childhood
Trauma Questionnaire (CTQ), and Mood Impairment (i.e., rated as ‘yes’ or ‘no’ using
SCID criteria for impairment and distress). Ratings from these measures will be used to
examine the potential moderating effects these risk factors may have on the relationships
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between participants’ age and their responses on the CUAPOS and the CUDPOS,
respectively. As previously described, of the total 727 participants, those who denied all
the items on the two respective scales (i.e., cases who reported a total score of zero on
both the CUAPOS and CUDPOS) were eliminated from the dataset, resulting in a sample
size of (N = 624). Although deleting cases with zero totals on the two combined scales
addressed some of the non-normality of the distribution of scale scores, follow up
exploratory analyses revealed that the data was highly skewed, with several outliers in
each respective scale. Log transformation was used in SPSS version 26 (IBM corp.,
2019), which corrects normality of the distribution of scores across Age Cohorts.
Exploratory analyses confirmed the statistical assumptions for Analysis of Variance
(ANOVA), including normality and homogeneity of variance, were met before the twoway (ANOVA) and Analysis of Covariance (ANCOVA) were used to examine possible
relationships between SUD risk factors and relationships between age cohort and scores
on each respective scale.
Comparisons of Age Cohort Differences on the CUAPOS
A one-way ANOVA comparing mean differences of participant scores on the
CUAPOS between the four different Age Cohorts (i.e., Young Adults, Adults, Middleage, and Old Adults) showed nonsignificant results (F (3, 620) = .368, p = .776). This
indicates that there are no significant age group differences in participants’ responses to
the CUAPOS items. Although results indicated no main effect between the independent
variable (IV), Age Cohort, and the dependent variable (DV), participant responses on the
CUAPOS, a series of two-way ANOVAs were conducted to evaluate the relationship
between Age Cohort (IV) and the participant scores on the CUAPOS, controlling for
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demographics and risk factors for substance abuse problems including, Race (White or
Persons of Color), Gender (Female or Male), ADHD (total score on the Adult ADHD
Self Report scale Symptom Checklist), Mood Impairment (Yes or No), Self-injury (total
score on the SIQ), and Childhood Trauma (total score on the CTQ).
Although the initial ANOVA examining Age Cohort differences on mean scores
on the CUAPOS was non-significant, follow up analyses controlling for confounding
variables were conducted. Two-way ANOVA was the statistical method used to examine
the mean changes in the relationship between Age Cohort and participant scores on the
CUAPOS when categorical variables including Race, Gender and Mood Impairment
were controlled for. Results showed nonsignificant interactions in mean differences on
Alcohol Abuse Problems scores between Age Cohorts and Gender (F (3, 616) = 1.284, p
= .279), as well as Age Cohorts and Mood Impairment (F (3, 616) = .899, p = .441).
An interaction between Age Cohort and Race and scores on the CUAPOS showed
statistical significance (F (3, 616) = 2.802, p = .039). Participants in the Person of Color
group who were in younger age cohorts (i.e., Young Adult and Adult), as well as the Old
Adult group, reported significantly less alcohol abuse problems than compared to the
Middle Age, Person of Color group. This group also scored significantly higher than the
White groups across Age Cohorts. Conversely, participants in Young Adult, Persons of
Color subgroup, reported significantly less alcohol abuse problems compared to all the
Age Cohorts in the White, sample as well as the three older Age Cohorts in the Persons
of Color group. Participants in the Age Cohorts, Adult and Old Adult, scored similarly on
the CUAPOS across race groups. Figure 1 is a line graph illustrating the significant
interaction effect between Age Cohorts and Race, on CUAPOS scores.
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The two-way ANOVA results also showed non-significant main effects between
the two IVs, Age Cohort (F (3,616) = 2.551, p = .055) and Race (F (1,616) = .088, p =
.766) and the DV (i.e., scores on the CUAPOS). Separate, follow up ANOVAs
examining the main effect of CUAPOS scores across the different Age Cohorts (F (3,
620) = .368, p = .776), as well as the main effect of CUAPOS scores across the Race
groups (F (1, 622) = .004, p = .947), yielded non-significant results. This suggests that
participants’ CUAPOS scores do not significantly differ between the four different Age
Cohorts. Therefore, the two IVs, Race and Age Cohort, show a significant interaction
effect on Alcohol Abuse Problems (DV), a finding not evident when race and age cohort
are not in the two-way ANOVA model together. It is important to note that this result
may be difficult to accurately interpret due to unequal sample sizes in each group with
the large majority being White (N = 548). In addition, this variable is limited in it’s
ability to provide descriptive information on race, given that the sample sizes of
individual race groups were too small for the present analyses.
A series of ANCOVAs showed nonsignificant results for the influence of
participant responses on the SIQ (F (3, 515) = .181, p =.909), the ASRS (F (3, 321) =
.328, p = .805), and the CTQ (F (3, 539) = .357, p = .784).
Comparisons of Age Cohort Differences on the CUDPOS
A one-way ANOVA comparing mean differences of participant responses on the scale
between the four different age cohorts (i.e., Young Adults, Adults, Middle-age, and Old
Adults) showed significant group differences (F (3, 620) = 3.728, p = .011). A follow up
Dunnett C test identified significant mean differences in responses to the CUDPOS
between the Young group and both the Middle-age (M = .307, SD = .115, p = .037) and
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the Old Adult (M = .377, SD = .122, p = .014) groups. Table 10 describes results from
ANOVAs assessing mean differences in scores on both the CUAPOS and the CUDPOS,
by Age Cohort.
A series of two-way ANOVAs were conducted to examine the influence
categorical IVs including Race (White or Persons of Color), Gender (Female or Male),
Mood Impairment (Yes or No) the mean differences in CUDPOS scores between Age
Cohorts. Results showed nonsignificant interactions in mean differences on CUDPOS
scores between Age Cohort and Gender (F (3, 616) = 2.489, p = .059), Age Cohort and
Race (F (3, 616) = .899, p = .441) and Age Cohort and Mood Impairment (F (3, 616) =
.349, p = .790). However, a significant main effect was found for the mean differences
between Female and Male responses on the CUDPOS (F (1, 616) = 7.526, p = .006). A
follow up one-way ANOVA was conducted to further assess the significant main effect
between Gender and participants’ scores on the CUDPOS (F (1, 622) = 5.446, p = .020).
These findings indicate that Age Cohort and Gender separately show main effects on
responses on the CUDPOS; however, when the interaction between Age and Gender is
considered in relation to mean differences in scores on the CUDPOS, the interaction
effect between the two IVs and the DV loses statistical significance (p = .059). Table 11
shows detailed results from the two-way ANOVA analyzing the mean differences in
CUDPOS scores across Gender and Age Cohort groups.
A series of ANCOVAs were conducted to compare mean group differences in
participant responses on the CUDPOS between Age Cohorts, while controlling for
covariates including Self-injury (total score on the SIQ), ADHD (total score on the
ASRS), and Childhood Trauma (total score on the CTQ). The influence of SIQ scores on
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the mean difference between CUDPOS scores by Age Cohort, was found to be nonsignificant (F (3, 510) = 1.815, p = .143); however, the SIQ was found to be significantly
related to the CUDPOS (F (1, 510) = 5.793, p = .016). Results also showed that ADHD
was not found to significantly influence the mean differences between Age Cohort group
scores on the CUDPOS (F (3, 321) = .748, p = .524). Overall, results show that
Childhood Trauma was the only significant covariate, moderating the mean differences in
CUDPOS scores between Age Cohort groups (F (3,539) = 2.848, p = .037). Further, the
CTQ and CUDPOS participant responses do not significantly relate to each other (F (1,
539) = 1.183, p = .277). These results show that Childhood Trauma does not directly
influence the DV, the CUDPOS, but it is a significant covariate that impacts the mean
differences between Age Cohorts and responses on the CUDPOS. Table 12 shows
detailed results for the significant influence childhood trauma appears to have on the
mean differences in CUDPOS scores between Age Cohorts.
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Discussion
The first goal of this study was to evaluate the psychometric properties of a
proposed scale to provide a clinically useful index of substance problems with
differentiation between alcohol and other substances. It was hypothesized that
generational differences in alcohol and substance problems would be found and that these
generational differences would be influence by other factors such as presence of
depression, anxiety, or ADHD history. The generational effects were assessed by
examined group comparisons in self-reported substance abuse and dependence problems,
across four different age groups, including Young Adult, Adult, Middle Age, and Older
Adult. As part of the MIDAS study at Rhode Island Hospital, participants reported
whether they experienced past year substance abuse in a SCID interview and SUD
problems were assessed by participants’ responses on two distinct scales in the Clinically
Useful Substance Abuse Problems Outcomes Scale, the CUAPOS and the CUDPOS. The
total sample (N = 1,620) represents psychiatric outpatients who disclosed past-year
substance abuse history in a SCID interview as part of the MIDAS study. Of the larger
sample of 1,620, 727 reporting past-year substance abuse and dependence, and 624
reporting at least one alcohol or drug related problem in the past week.
For the first study goal a series of exploratory, confirmatory, and metric
invariance analyses were used to examine the factor structure of the proposed CUSAPOS
measure. This graded set of analyses found that the items of the CUSAPOS were not best
characterized as one scale with two factors that assess substance and alcohol use.
Instead, measure development analyses suggested that the 15 items each assessing
alcohol or drug use be treated as separate scales entirely. Exploratory factor analysis
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conducted separately on each of the 15-item drug and alcohol item sets supported a twofactor structure for each independent scale (name the two factors). Confirmatory
analyses supported the two-factor structure of each new scale; the Clinical Useful
Alcohol Problems Outcomes Scale (CUAPOS) and the Clinically Useful Drug Problems
Outcomes Scale (CUDPOS). However, these new scales were not found to be invariant
by age grouping suggesting that the interpretation of the items for each scale varied from
one age group to another. Multigroup CFAs confirmed good model fit across Age
Cohorts for both the CUAPOS and the CUDPOS. Two-way ANOVAs and ANCOVAs
were used to examine the influence confounding variables that represent demographic
characteristics (i.e., Race, Gender), as well as SUD risk factors (i.e., Mood Impairment,
ADHD, Childhood Trauma, and Self-Injury), which may influence the mean differences
in participants responses to the respective CUSAPOS subscales, between the four Age
Cohorts.
Analyses comparing drug abuse problems (i.e., drug categories:
sedatives/hypnotics/anxiolytics, cannabis, stimulants, opioids, cocaine, and
hallucinogens) across the four age cohorts (i.e., Young Adults, Adults, Middle Age, and
Old Adults) revealed that cannabis was overwhelmingly the most common substance
abused across age groups. This finding is consistent with national and global reports
indicating that the perception of harm from cannabis use is decreasing overtime, and
consequently, the rates of cannabis abuse continue to increase over the time. This appears
to be a growing problem in all age groups. Descriptive results also showed that compared
to other Age Cohorts, the Middle Age group showed the highest rates of substance abuse
(i.e., across drug type categories). This finding is consistent with statistics from the 2015-
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2016 National Survey on Drug Use and Health (NSDUH) showing a growing concern of
increasing rates of SUD problems in middle age and old adult populations (Perlman,
2019). In fact, Han and Palamar (2018) examined trends of marijuana use in middle-aged
and older Americans found that the percentage of respondents age 50 to 64 (9%) and the
percentage of respondents age 65 and older (2.9%) reporting use of marijuana during the
past year “…represented increases of 27 percent and 107 percent compared with the
2012–2013 NSDUH; and 100 percent and 625 percent compared with the 2006–2007
survey” (Perlman, 2019). Moreover, results from the 2015-2016 NSDUH also showed
that rates of marijuana use were three times more prevalent in middle aged participants
than in the older group (Han & Palamar, 2018; Perlman, 2019). The prevalence of
marijuana use in the Middle Age cohort compared to the Old Age cohort in the present
study, appears to be similar, but slightly less than the national averages reported in a
similar time frame as the year the data were collected for the present study (the Middle
Age cohort reported approximately 2.5 times more past-year marijuana use compared to
the Old Age cohort). These findings represent a growing public health risks, especially
given that additional analyses show strong associations between marijuana use later in
life and higher likelihood to struggle with cocaine abuse, prescription opioid misuse,
nicotine dependence and major depression (Perlman, 2019). Of note, older past-year
marijuana users are at approximately 8 times greater odds of cocaine use than those who
did not report using marijuana in the past year (Han & Palamar, 2018). Therefore, the
high rate of past year cocaine abuse (13.1%), as well as stimulant abuse (7.3%), in the
Middle Age cohort compared to all the other age groups, in the present study, may be
representative of national trends.
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National statistics suggest that the problem of the heroin and prescription opioid
and benzodiazepine misuse may be growing exponentially in U.S. older populations.
Huhn, Strain, Tompkins, and Dunn (2018) examined the rates of first-time treatment
admissions for primary opioid use disorder in adults age 55 and older and they found that
they almost doubled in this population since 2007, with the sharpest increase occurring
between 2013 and 2015 (53.5%), with the large majority being heroin abusers. These
rapid increases in the rates of opioid abuse disorder in older adults contrast the steady
increase in younger populations, with approximately 10% more first-time treatment
admissions per year since 2007 (Huhn et al., 2018).
Research findings also suggest a significant link between prescription opioid and
benzodiazepine abuse and misuse in older populations. Schepis, Simoni‐Wastila, and
McCabe (2019) analyzed the 2015-2016 NSDUH data to examine the potential risks
associated with prescription misuse in adults age 50 and older. They found that those
participants who misused both prescription opioids and benzodiazepines, were 10 times
more likely to have serious suicidal ideations then those who did not misuse these
substances in the past year (Schepis et al., 2019). Unfortunately, little is understood about
this special risk in older populations and more research is needed to better understand
additional health risks associated with the co-administration and misuse of both
benzodiazepines and opioids (Maree et al., 2016). The present study shows similar rates
between opioid and sedative/hypnotic/anxiolytic past year abuse in the Middle Age
Cohort, the age group that showed significantly higher rates of past year misuse of those
substances in comparison to the age cohorts. Future research examining the health risks
related to prescription opioid misuse, combined with benzodiazepine misuse, in the
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present study’s older groups may reveal meaningful insights for prescribing
practitioners.
Principal components analyses (PCAs) exploring factor structure within each
distinct scale (i.e., the CUAPOS and CUDPOS), revealed a similar two-factor structure
for both scales. The two scales share conceptually similar two factor structures, with one
factor’s items appearing to assess cognitions associated with one’s own substance use
(i.e., one’s self-awareness of their substance abuse problems), and the other assessing for
behaviors associated with SUD. However, the PCA results as well as the orthogonal (i.e.,
near zero correlation) suggest that the two scales may be conceptually different.
A series of confirmatory factor analyses (CFAs) were performed in order to
confirm the factor structure found in PCAs for each respective scale and find the best
fitting model for each scale across age groups. This procedure was necessary in order to
find the best model fit for both the CUAPOS and the CUDPOS across Age
Cohorts. CFAs on the overall sample showed good fit for the two-factor structure in each
respective scale, across age groups. Measurement invariance testing using multi-level
CFAs showed non-invariance in both the CUAPOS and the drug abuse problem scale,
suggesting that there are meaningful differences in how participants responded to each
scale based on their age cohort. This result may reflect national trends showing key
differences between youth and older adult substance abusers (NSDUH 2018).
A one-way ANOVA examining Age Cohort comparisons of mean scores on the
CUAPOS showed nonsignificant differences across Age Cohorts on the CUAPOS. The
only notable group differences found from conducting two-way ANOVAs and
ANCOVAs, may be a significant interaction effect between Race and Age Cohort on
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CUAPOS however no main effect was found between Race and participant scores on the
CUAPOS. The interaction showed that Persons of Color in the Young Adult group
scored significantly lower on the CUAPOS than the other Age Cohort groups, including
the Adult, Middle Age, and Older Adult groups. Results from this analysis also shows
that the Young Adult, Person of Color, group endorsed significantly less problems on the
CUAPOS compared to White participants in the Young Adult group. Results appears to
be consistent with national reports indicating that alcohol abuse in youth populations has
continued trending down since 2015. Research also supports the present study’s finding
that young Persons of Color may be at less risk for severe alcohol use disorder compared
to White youth. Several psychosocial factors may explain this difference in youth
populations, including peer use, parental factors, and religiosity (Dickens , Jackman,
Stanley, Swaim, & Chavez, 2018; Su et al., 2020). Dickens and colleagues (2018)
compared the prevalence and effects of psychosocial risk factors for alcohol abuse
problems between White and African American rural adolescents. They found that
religiosity, peer use, and parental permissiveness were factors that were more strongly
associated with increasing the risk of alcohol abuse in White youth compared to African
American youth. Although racial discrimination has been shown to increase the risk of
African American youth abusing alcohol and other substances, appropriate racial
socialization by peers has been shown to be a significant protective factor from alcohol
abuse problems in young Persons of Color (Su et al., 2020). In contrast, the Middle Age,
Persons of Color group showed significantly higher reports of alcohol abuse problems
than any other Age Cohort across both Race groups. Research examining differences in
alcohol abuse problems and socioeconomic factors points to lacking education and poor
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social support as risk factors that have a significantly greater impact on middle age or
older adults in African American populations compared to Whites (Karriker-Jaffe,
Witbrodt, & Mulia, 2019). One of the potential consequence of these low education
attainment and poor social support, economic disadvantage, is one of the greatest risk
factors for alcohol use disorder in Middle Age populations in African American
communities (Assari, Smith, Mistry, Farokhnia, & Bazargan,, 2019). It is important to
note that these results may be difficult to interpret due to unequal sample sizes in each
group with the large majority being White (N = 548) and the Persons of Color group
being much smaller (N = 76). In addition, this variable is limited in its ability to provide
descriptive information on race and ethnicity, given that the sample sizes of individual
race groups were too small (N < 50) to be examined as more descriptive race groups in
the present analyses.
Group Comparisons for the CUDPOS
A one-way ANOVA examining mean differences in participants’ responses to
items on the CUDPOS between Age Cohorts, found significant differences between the
Young Adult group and two other Age Cohorts: Middle Age and Old Adults. This
finding is consistent with the results from the present study’s chi-square tests, describing
the prevalence of drug abuse problems within each Age Cohort. Moreover, results from
both the initial ANOVA and crosstabulations (chi-square tests) comparing drug abuse
problems showed results that are consistent with national and global trends. While both
national and global SUD trends show a progressive decrease in abuse of alcohol and most
illicit drugs, public health officials are concerned that certain drug abuse, especially
cannabis abuse, is becoming more socially acceptable. This is of particular concern in
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youth populations, given that national and global trends indicate that they (i.e., ages 12 to
25) are the age group most likely to perceive cannabis abuse as having low health risks,
and therefore, they are at highest risk for engaging in cannabis abuse early in life,
particularly before age 19 (NSDUH 2018; Lipari et al, 2017). There is evidence that
suggests the trending increase in cannabis abuse also puts youth at risk for developing
problems with cocaine abuse, nicotine dependence, major depression, and prescription
opioid abuse later in life (Perlman, 2019).
A two-way ANOVA examining the interaction effect of age and gender on
participants’ reported drug abuse problems. Results showed a nonsignificant interaction
effect between age and gender on drug abuse problems, similar to age, gender showed a
main effect on drug abuse problems across Age Cohorts. Figure 1 shows significant
differences and similarities comparing the two gender groups across the four different age
groups (i.e., Young Adult, Adult, Middle Age, and Older Adult). The most dramatic
differences in drug abuse problems between gender groups are shown in early adulthood
(i.e., Young Adult and Adult age groups), with females reporting significantly less drug
abuse problems than males, most notably in the Adult age group. In fact, the mean score
on the CUDPOS in the male, Adult age group, was the highest compared to the other
male age groups, whereas the female, Adult age group scored the lowest compared to the
other female age groups, with the most dramatic decrease showing between the Young
Adult and Adult female groups. Research suggests that the differences between male and
female drug abuse behaviors are nuanced. A recent cross-sectional study, based on
interview data from Swedish adolescents in outpatient clinics, found that females tend to
have more severe substance abuse consequences, and risk factors, including more
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difficult home environments than boys, and are more likely to have problems related to
school, more serious substance abuse problems, and more severe mental health problems
(Anderberg & Dahlberg, 2018). Anderberg and Dahlberg (2018) highlighted a “gender
paradoxical relationship” in which females enter treatment for substance abuse problems
at much lower rates than men; however, females who struggle with SUD tend to
experience more life problems. Reports from the 2017 NSDUH data show that while
much of the current research and public support for the opioid epidemic is aimed at
women, there is a rapidly growing problem of opioid use disorder and prescription drug
misuse among U.S. males (Silver & Hur, 2020).
An ANCOVA examining the moderating effect that childhood trauma may have on the
mean differences in CUDPOS scores between age groups, revealed that childhood trauma
is a significant covariate that influences the significant relationship between age and drug
abuse problems. This finding is consistent with research showing that Adverse Childhood
Events (ACEs), significantly predict life-time substance abuse problems, starting in
adolescence and into older adulthood (Choi, DiNitto, Marti, & Choi, 2017). While ACEs
similarly predict SUD outcomes across demographic groups, notable differences between
gender and racial groups who are victims of childhood trauma who struggle with SUD
throughout adulthood. Choi and colleagues (2017) examined data (N = 14,738 for the 50
and older age group), from the 2012 to 2013 National Epidemiologic Survey on Alcohol
and Related Conditions. They found that boys who experience ACEs are more likely to
develop antisocial behaviors early in young adulthood compared to girls who report
similar ACEs, and White participants reported greater adverse mental health impact
compared to Blacks and Hispanics with similar ACEs. A study examining the
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relationship between childhood trauma and SUDs, found significant correlations between
levels of childhood trauma, including physical, sexual, and emotional abuse, substance
abuse (particularly cocaine abuse), and current PTSD symptoms (Khoury et al., 2010). In
fact, the authors explained that while controlling for exposure to adult trauma, a
significant additive effect of the number of different types of childhood trauma,
combined with a history of cocaine dependence was found to be predictive of current
PTSD symptoms (Khoury et al., 2010). Future research examining data from the MIDAS
project may reveal additional insights regarding the relationship between childhood
trauma and SUD.
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Limitations
Given that substance abuse behaviors are typically under-reported, self-report
measures may provide a limited view of the scope and severity of SUD within this
sample (Tourangeau and Yan, 2007). This issue may be due to lack of insight regarding
the severity of problems associated with SUD, fear of repercussions, or social
desirability. Moreover, while the participants included in the two-way ANOVA and
ANCOVAs examining demographic characteristics and SUD risk factors (i.e., race, sex,
mood impairment, childhood trauma, self-injury, and ADHD) endorsed at least one
substance abuse or dependence related problem in the past week (i.e., on the CUAPOS or
the CUDPOS), many participants in the present sample did not respond to information on
every measure used in the present analyses. For example, of the total sample that
completed the self-report questionnaires (N= 624), approximately half of these
participants completed the ASRS (n= 326). Therefore, interpretations of the results from
the present analyses should consider the potential for under-reporting.
Another potential limitation of this sample is that participants were recruited from
an outpatient mental health setting. This sample may represent a subsample of patients
with SUD who are more willing to seek treatment and are currently experiencing less
severity of symptoms than those in partial and inpatient mental health or residential
rehabilitation programs. Moreover, the participants are privately insured, and research
consistently shows a longstanding history of healthcare disparities between the insured
and uninsured or underinsured U.S. patient populations (Angier et al., 2017). Overall,
research suggests that uninsured patients are significantly less likely to seek healthcare
services because of low quality of care, and limited availability of outpatient
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appointments compared to insured patients. Given that poorer healthcare resources puts
one at risk for mental health problems and SUD, it can be assumed that the results from
the present study may vary between patient populations with different socioeconomic
backgrounds. Therefore, the generalizability of these findings to the SUD population
overall may be limited such that the present study’s sample may represent a more
privileged group of treatment seeking patients.
Lastly, a major limitation in the present study overall, is that the Chi-square
difference tests on the two respective scales of interest (the CUAPOS and the CUDPOS)
show non-invariance between Age Cohorts. This means that while the overall goodness
of fit indices for the total sample (N= 577), as well as the goodness of fit indices within
each Age Cohort showed good model fit, the manner in which participants in different
age groups interpret and respond to items is different for each respective scale. Given that
the nature of these age group differences in the present study’s sample is unclear,
interpretation of results from the ANCOVA and two-way ANOVAs following the
multigroup CFAs, should be interpreted with caution.
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Suggestions for Future Research
It is important to note that the measurement development portion of the present
study does not include participants who denied past year drug abuse in their SCID
interviews, potentially eliminating useful information from participants who identify as
recovering addicts who have stayed sober past one year, and those who have no SUD
history. Qualitative data from the non-substance abusers in the overall MIDAS project
sample may provide useful insights on stigma and other sociocultural issues related to
SUD problems. The role of the patient’s primary care physician (e.g., medication
management, SUD assessment, and SUD treatment) is another important area to explore
in future research. Physician stigma against patients struggling with SUD has been shown
to have a negative impact on patient empowerment and treatment outcomes (Van Boekel,
Brouwers, Van Weeghel, & Garretsen, 2013). Therefore, in addition to better
understanding how stigma in the general population may negatively impact SUD
problems, the influence that physician biases about substance abuse may have on their
patients’ assessment and treatment outcomes, may be another important area to explore in
future research.
Given that generalizability of the present study’s sample may be limited, due to
factors such as insurance status (i.e., sample is limited to privately insured patients) and
substance abuse and dependence status (i.e., sample is limited to patients with past-year
substance), and small group sizes in some of the study’s variables (e.g., Race), replication
of this study with a larger, more diverse sample of participants who report past-year
substance abuse may provide different results. A larger, randomized sample would likely
yield more statistical power and therefore provide more reliable results. In summary, new

46

measurement development efforts to improve the CUDPOS and CUAPOS scales are
necessary to ensure invariance of the measures by age groups. This effort could also
evaluate the invariance of the new scales by potentially important demographic groups
such as gender or race. This research has the potential to provide two novel, and reliable
screeners for alcohol and drug abuse problems that physicians can efficiently utilize in
outpatient settings in order to improve the treatment outcomes of patients from diverse
demographic groups.
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Appendix A

1. How often do you have trouble wrapping up the final
details of a project once the challenging parts have been
done?
2. How often do you have difficulty getting things in order
when you have to do a task that requires organization?
3. How often do you have problems remembering
appointments or obligations?
4. When you have a task that requires a lot of thought, how
often do you avoid or delay getting started?
5. How often do you fidget or squirm with your hands or feet
when you have to sit down for a long time?
6. How often do you feel overly active and compelled to do
things, like you were driven by a motor?
7. How often do you make careless mistakes when you have
to work on a boring or difficult project?
8. How often do you have difficulty keeping your attention
when you are doing boring or repetitive work?
9. How often do you have difficulty concentrating on what
people say to you, even when they are speaking to you
directly?
10. How often do you misplace or have difficulty finding
things at home or at work?
11. How often are you distracted by activity or noise around
you?
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Very often

Often

Sometimes

Rarely

Instructions:
Please answer the questions below, rating yourself on each of
the criteria shown using the scale on the right side of the page.
As you answer each question, place an X in the box that best
describes how you have felt and conducted yourself over the
12ast 6 months.

Never

Adult ADHD Self-Report Scale

Very often

Often

Sometimes

Rarely

Never

Instructions:
Please answer the questions below, rating yourself on each of
the criteria shown using the scale on the right side of the page.
As you answer each question, place an X in the box that best
describes how you have felt and conducted yourself over the
12ast 6 months.
12. How often do you leave your seat in meetings or other
situations in which you are expected to remain seated?
13. How often do you feel restless or fidgety?
14. How often do you have difficulty unwinding and relaxing
when you have time to yourself?
15. How often do you find yourself talking too much when
you are in social situations?
16. When you're in a conversation, how often do you find
yourself finishing the sentences of the people you are
talking to, before they can finish them themselves?
17. How often do you have difficulty waiting your turn in
situations when turn taking is required?
18. How often do you interrupt others when they are busy?

(Kessler, et al., 2005)
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Appendix B
Childhood Trauma Questionnaire
Instructions: These questions ask about some of your experiences growing
up as a child and a teenager. For each question, circle the number that best
describes how you feel. Although some of these questions are of a personal
nature, please try to answer as honestly as you can. Your answers will be
kept confidential.
Never Rarely Sometimes Often
true
true
true
true
1.

There was someone in my family
whom I could talk to about my
problems.

2.

People in my family criticized me.

3.

I didn't have enough to eat.

4.

People in my family showed
confidence in me and encouraged
me to succeed.

5.

Someone in my family hit me or
beat me.

6.

I lived in a group or foster home.

7.

I knew that there was someone to
take care of me and protect me.

8.

Someone in my family yelled and
screamed at me.

9.

I saw my mother or one of my
brothers or sisters get hit or
beaten.

10. People in my family called me
things like "stupid," "lazy," or
"ugly."
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Very
often
true

Never Rarely Sometimes Often
true
true
true
true
11. I was living in the streets by the
time I was a teenager or even
younger.
12. There was someone in my family
whom I admired and wanted to be
like.
13. My parents were too drunk or high
to take care of the family.
14. People in my family got into
trouble with the police.
15. There was someone in my family
who helped me feel that I was
important or special.
16. I had to protect myself from
someone in my family by fighting,
hiding, or running away.
17. There was someone in my family
who wanted me to be a success.
18. I had to wear dirty clothes.
19. I lived with different people at
different times (like different
relatives or foster families).
20. I believe that one of my brothers or
sisters might have been molested.
21. I felt loved.
22. My parents tried to treat all of
children the same.
23. I thought that my parents wished I
had never been born.
24. I got hit so hard by someone in my
family that I had to see a doctor or
go to the hospital.
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Very
often
true

Never Rarely Sometimes Often
true
true
true
true
25. There was someone in my family
who made sure that I stayed out of
trouble.
26. People in my family hit me so hard
that it left me with bruises or marks.
27. I had sex with an adult or with
someone who was a lot older than
me (someone at least 5 years older
than me).
28. There was someone older than
myself (like a teacher or a parent)
who was a positive role model.
29. I was punished with a belt, a board,
a cord, or some other hard object.
30. There was nothing I wanted to
change about my family.
31. People in my family looked out for
each other.
32. People in my family said hurtful or
insulting things to me.
33. I believe that I was physically
abused.
34. People in my family tried to keep
me away from bad influences.
35. I got hit or beaten so badly that I
was noticed by someone like a
teacher, neighbor, or doctor.
36. People in my family seemed out of
control.
37. People in my family encouraged me
to stay in school and get an
education.
38. I spent time out of the house, and
no one knew where I was.
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Very
often
true

Never Rarely Sometimes Often
true
true
true
true

Very
often
true

39. The punishments I received seemed
cruel.
40. Someone in my family hated me.
41. People in my family felt close to
each other.
42. Someone tried to touch me in a
sexual way or tried to make me
touch them.
43. People in my family pushed me or
shoved me.
44. Someone threatened to hurt me or
tell lies unless I did something
sexual with them.
45. I had the perfect childhood.
46. I was frightened of being hurt by
someone in my family.
47. Someone tried to make me do
sexual things or watch sexual
things.
48. Someone in my family believed in
me.
49. Someone molested me.
50. I believe that I was emotionally
abused.
51. I believe that I was emotionally
abused.
52. I believe that I was sexually abused.
53. My family was a source of strength
and support.
(Bernstein, Fink, Handelsman, & Foote, 1994)
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Appendix C
Self-Injury Questionnaire
In the past 3 months, have you done any of the following to deliberately
hurt yourself?
1.

Cut yourself with a sharp object

2.

Scratched yourself?

3.

Hit yourself?

4.

Burned yourself?

5.

0

1

2

3

0

1

2

3

0

1

2

3

0

1

2

3

Picked areas of your body to the point of
drawing blood?

0

1

2

3

6.

Banged your head, arms, or legs to the point of
bruising?

0

1

2

3

7.

Pulled out your hair?

0

1

2

3

8.

Chewed the inside of your mouth to the point of
bleeding?

0

1

2

3

9.

Hurt yourself while masturbating?

0

1

2

3

10.

Cut, burned, or scratched your genitals?

0

1

2

3

0

1

2

3

0

1

2

3

0

1

2

3

11. Picked at wounds?
12. Carved words on your skin?
13.

Other damage to your body?

Specify:
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Table 1.
Crosstabulations Comparing Past-year Drug Abuse and Dependence by Drug Type Across Four Age Cohorts in A Sample Of
1,620 Psychiatric Outpatients
Drug Type
Sedatives/
Hypnotics/
Anxiolytics
Ages

Cannabis

Stimulants

Opioids

Hallucinogens

Cocaine

Past-year Abuse
(Yes/No)

n

%

n

%

n

%

n

%

n

%

n

%

Yes

41a

3.0

344a

21.2

32a

2.0

60a

3.7

75a

4.6

51a

3.1

No

322a

19.9

19a

1.2

331a

20.4

303a

18.7

288a

17.8

312a

19.3

Yes

39a

2.4

380b

23.5

43a

2.7

65a

4

147b, c

9.1

70a

4.3

No

394a

24.3

53b

3.3

390a

24.1

368a

22.7

286b, c

17.7

363a

22.4

Yes

105b

6.5

492b

30.4

119b

7.3

99a

6.1

212c

13.1

85a

5.2

No

477b

29.4

90b

5.6

463b

28.6

483a

29.8

370c

22.8

497a

30.7

Yes

38a, b

2.3

218a, b

13.5

45b

2.8

35a

2.2

60a, b

3.7

27a

1.7

No

204a, b

12.6

24a, b

1.5

197b

12.2

207a

12.8

182a, b

11.2

215a

13.3

18-25
26-35
70
36-49

50 +
χ2 (p-value)

< .001**

< .001**

< .001**

.74

< .001**

.36

Notes. Chi-square analyses were used to compare past year drug abuse between Age Cohorts, within each drug type. Each subscript
letter denotes a subset of Age Cohorts categories whose column proportions do not differ significantly from each other (p > .05).
** Statistical significance at the p < .01 level

Table 2.
Descriptive Characteristics Including Gender and Race by Age Cohort in a Sample With Pastyear Substance Abuse and Dependence (N = 727)
Demographic
Characteristics

Age Cohort

Young Adult
Gender
Female
Male
Race
White
Black
Hispanic
Asian
Portuguese
Other
Total

Adult

Middle Age

Old Adult

Full Sample

n

%

n

%

n

%

n

%

n

%

98
83

13.5
11.4

83
64

11.4
8.8

128
111

17.6
15.3

76
84

10.5
11.6

385
342

53.0
47.0

157
11
6
4
2
1
181

21.6
1.5
0.8
0.6
0.3
0.1
24.9

127
7
5
5
2
1
147

17.5
1.0
0.7
0.7
0.3
0.1
20.2

209
11
5
1
6
7
239

28.7
1.5
0.7
0.1
0.8
1.0
32.9

147
6
1
1
6
0
160

20.2
0.8
0.1
0.0
0.8
0.0
22.0

640
35
17
10
16
9
727

88.0
4.80
2.30
1.40
2.20
1.20
100

Note. This sample was split for confirmatory factor analyses (N= 577) and principal
components analyses (N= 150).
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Table 3.
Descriptive Characteristics Including Gender, and Race, By Age Cohort in The
Subsample Used for Principal Components Analyses (N = 150)
Descriptive
Characteristic

Age Cohort
Young
Adult

Adult

Middle
Age

Old Adult

Full Sample

n

%

n

%

n

%

n

%

n

%

Female

16

10.7

20

13.3

30

20.0

19

12.7

85

56.7

Male

14

9.3

11

7.3

23

15.3

17

11.3

65

43.3

White

27

18.0

25

16.7

49

32.7

35

23.3

136

90.7

Person of
Color

3

2.0

6

4.0

4

2.7

1

.7

14

9.3

Gender

Race
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Table 4.
Exploratory Factor Structure of the Initial 30 Items in the CUSAPOS (N= 150)
Scale Items

Factor Loadings
Factor 1: Factor 2:
Alcohol
Drug
Problems Problems
.712

M

SD

63. I was intoxicated from alcohol.

1.03

1.187

64. I drink alcohol more than I should.

.99

1.253

.855

65. Others complained about my drinking.

.45

.959

.656

66. I thought my drinking was a problem.

.68

1.076

.786

67. I had more than three drinks of alcohol in a day.

.99

1.232

.769

68. I thought about cutting down or stopping
drinking.

1.05

1.375

.768

69. I tried to limit the amount of drinking I did.

1.15

1.407

.676

70. I tried to cut down or stop drinking.

.99

1.318

.682

71. I couldn’t stop drinking when I wanted to.

.47

.995

.827

72. I had a strong urge to drink alcohol.

.92

1.256

.610

73. I drove after having two or more drinks of
alcohol.

.57

1.089

.667

74. I was hung over from drinking alcohol

.58

1.070

.624

75. I drink alcohol during the morning.

.19

.642

.574

76. I drank alcohol even though it caused problems
in my life.

.41

.928

.777

77. I felt guilty about my drinking of alcohol.

.56

1.096

.757

78. I was high on drugs.

.57

1.149

-

79. I used street drugs.

.46

1.066

80. I used drugs more than I should.

.45

1.114

81. I thought that my drug use was a problem.

.35

.969

73

-

.791
.723
.913
.849

Scale Items

Factor Loadings
M

SD

82. others complained about my drug use.

.37

1.019

83. I thought about cutting down or stopping my
drug use.

.57

1.239

84. I tried to limit the amount of drugs I use.

.51

1.191

85. I tried to cut down or stop my drug use.

.48

1.168

86. I couldn't stop using drugs when I wanted to.

.31

.919

87. I had a strong urge to use drugs.

.50

1.145

88. I drove after using drugs.

.43

1.039

89. I felt depressed after or paranoid after using
drugs.

.29

.892

90. I use drugs in the morning.

.35

.997

91. I use drugs even though it caused problems in
my life.

.34

.954

92.I felt guilty about my drug use.

.49

1.169

Factor 1:
Alcohol
Problems
-

Factor 2:
Drug
Problems
.813
.938
.855
.834
.803
.816
.772
.617
.643
.835
.898

Note. Principal components analysis, with a promax (oblique) rotation, was the statistical
method used to explore the factor structure of the total 30 items in the proposed CUSAPOS
measure.
M= mean; SD = standard deviation.
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Table 5.
Confirmatory Factor Structure and Factor Loadings of Items in the CUAPOS and
CUDPOS
Scale Items

Factor Loadings
M

SD

Factor 1:
Insighta

Factor 2:
Behaviorsb

.99

1.25

.758

.144

.45

.96

.801

-.046

.68

1.08

.077

.827

.99

1.23

.811

-.008

.99

1.32

-.169

.905

73. I drove after having two or more drinks of
alcohol.

.57

1.09

.928

-.190

75. I drink alcohol during the morning.

.19

.64

.490

.226

76. I drank alcohol even though it caused
problems in my life.

.41

.93

.574

.316

77. I felt guilty about my drinking of alcohol.

.56

1.0

.070

.807

78. I was high on drugs.

.57

1.15

.340

.542

81. I thought that my drug use was a problem.

.35

.97

.800

.140

82. others complained about my drug use.

.37

1.02

.937

-.092

85. I tried to cut down or stop my drug use.

.48

1.17

.637

.270

.31

.92

.768

.130

CUAPOS
64. I drink alcohol more than I should.
65. Others complained about my drinking.
66. I thought my drinking was a problem.
67. I had more than three drinks of alcohol in a
day.
70. I tried to cut down or stop drinking.

CUDPOS

86. I couldn't stop using drugs when I wanted to.
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Scale Items

Factor Loadings
M

SD

Factor 1:
Insighta

Factor 2:
Behaviorsb

89. I felt depressed after or paranoid after using
drugs

.29

.892

-.297

1.085

90. I use drugs in the morning

.35

.997

.916

-.269

91. I use drugs even though it caused problems in
my life

.34

.954

.405

.570

CUDPOS

Notes. Factor loadings that were confirmed with confirmatory factor analyses. Each scale
shows a two-factor structure, and the number in bold indicates which factor that item
loading appears to represent. Log transformation was used to correct normality of the
distribution of scores across Age Cohorts.
M = mean score; SD = standard deviation
a. Items reflect one’s insight or self-awareness of substance abuse problems
b. Items reflect behaviors associated with substance abuse problems
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Table 6.
Goodness of Model Fit for the CUAPOS and CUDPOS by Age Cohort
CUAPOS
Age Cohort

Goodness-of-fit Indices
χ2
(p value)

N

DF

CFI

TLI

RMSEA

SRMR

Young Adult

152

26

0.996

0.994

0.070

0.073

0.011

Adult

132

26

.999

0.998

0.051

0.080

0.144

Middle Age

201

26

1.0

1.0

0.014

0.044

0.410

Older Adult

139

26

1.0

1.0

0.016

0.074

0.417

Full Sample

624

36

0.997

0.995

0.064

0.046

> .001

CUDPOS
Age Cohort

Goodness-of-fit Indices
N

DF

CFI

TLI

RMSEA

SRMR

χ2
(p value)

Young Adult

152

19

1.0

1.0

0.0

0.043

0.58

Adult

132

19

1.0

1.0

0.0

0.033

0.868

Middle Age

201

19

1.0

1.0

0.0

0.026

0.981

Older Adult

139

19

1.0

1.0

0.0

0.070

0.722

Full Sample

624

28

0.972

0.958

0.081

0.031

> .001

Note. Confirmatory factor analyses showed good model fit across Age Cohorts for
both scales.
N = number of participants; DF = degrees of freedom; CFI = comparative fit index;
TLI = Tucker–Lewis index; RMSEA = root mean error of approximation; SRMR =
standardized root mean square residual
χ2 (p value) = Chi-square test statistical significance at the p < .05 level.
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Table 7.
Multigroup Confirmatory Factor Analyses for the CUAPOS and CUDPOS
CUAPOS
Model (M)

χ2 (df)

CFI

TLI

M1:
Configural
Invariance

348.99
(104)

0.914

M2:
Weak/Metric
Invariance

415.85
(125)

0.898

0.054

Model
comp
--

Δχ2
Decision
(Δdf)
---

0.088

M1

66.86
(21)

Δχ2
(Δdf)
--

57.36
(18)

RMSEA

SRMR

0.881

0.128

0.883

0.127

Reject

CUDPOS
Model (M)

χ2 (df)

CFI

TLI

RMSEA

SRMR

M1:
Configural
Invariance

332.60
(76)

0.913

0.872

0.153

0.050

Model
comp
--

M2:
Weak/Metric
Invariance

389.96
(94)

0.900

0.881

0.148

0.094

M1

Decision
--

Reject

Note. Invariance test results show non-invariance in participant responses to items on both
the CUAPOS and the CUDPOS, across Age Cohorts.
Δχ2 (Δdf) = Chi-square difference between M1 and M2 (degrees of freedom);
CFI = comparative fit index; TLI = Tucker–Lewis index; RMSEA = root mean error of
approximation; SRMR = standardized root mean square residual
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Table 8.
Descriptive Statistics and Correlations of the Study Scales
Scale

n

M

SD

1

1. CUAPOS

624

6.63

7.4

-

2. CUDPOS

624

3.24

6.15

0.02

3. Adult ADHD Self-Report
Scale (ASRS)

326

35.39

12.67 0.02 .15**

4. Self-Injury Questionnaire
(SIQ)

515

2.04

3.56

5. Childhood Trauma
Questionnaire (CTQ)

544

0.04

2

3

4

5

-

-

.09*

.26**

-

106.78 45.88 0.01 -.09*

0.07

0.07

Notes. Table 8 shows significant correlations between scores on the CUDPOS
and three other scales: ASRS, SIQ, and CTQ. The ASRS and SIQ also show a
significant relationship.
n= total number of participants who completed the respective scale; SD=
standard deviation; M= mean scores
** Correlation is significant at the p < .01 level
* Correlation is significant at the p < .05 level
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Table 9.
Descriptive Characteristics for Gender, Race, and Mood Impairment by Age Cohort in a Sample Who
Reported Substance Abuse Problems in the Past Week (N= 624)
Descriptive
Characteristic

Age Cohort
Young Adult

Adult

Middle Age

Old Adult

Full Sample

n

%

n

%

n

%

n

%

n

%

Female
Male

80
72

12.8
11.5

71
61

11.4
9.8

104
97

16.7
15.5

67
72

10.7
11.5

322
302

51.6
48.4

White
Person of Color
Impairment/
Distress
No
Yes

133
19

21.3
3.0

113
19

18.1
3.0

175
26

28.0
4.2

127
12

20.4
1.9

548
76

87.8
4.8

91
61

14.6
9.8

57
75

9.1
12.0

100
101

16.0
16.2

66
73

10.6
11.7

314
310

50.3
49.7

Total Sample

152

24.4

132

21.2

201

32.2

139

22.3

624

100

Gender

Race
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Notes. Crosstabulations describe the variables Race, Gender, and Mood Impairment by Age Cohort in a
subsample who reported experiencing at least one alcohol or drug problem in the past-week. This
subsample was used for analyses comparing mean scores on the CUDPOS and CUAPOS by Age Cohort,
while controlling for Race, Gender, and Mood Impairment.

Table 10.
Comparisons of Mean Scores on the CUAPOS and the CUDPOS by Age Cohort

Scale

Dunnett’s
C Test
Results

0. Young
Adult
(N= 152)

1. Adult
(N= 132)

2. Middle
Age
(N=201)

3. Older
Adult
(N=139)

M (sd)

M (sd)

M (sd)

M (sd)

1.52
(1.04)

1.62 (.96)

1.59
(1.02)

F (3, 620) =
.368, p = .776

ns

.65 (1.01)

.58 (.98)

F (3, 620) =
3.728, p = .011

0 < 2, 3

CUAPOS 1.54 (.97)

CUDPOS .96 (1.10) .79 (1.16)

ANOVA

Notes. ANOVA results comparing mean scores on the CUAPOS and CUDPOS, show
significant differences in self-reported drug abuse problems between the Young Adult
and the Middle Age and Older Adult groups. No significant differences were found
between Age Cohorts in alcohol abuse problems.
ns= non-significant; M= mean score; sd= standard deviation
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Table 11.
Two-way ANOVA on CUDPOS Scores by Age Cohort by Gender
Predictor
Intercept
Age Cohort
Gender
Age Cohort x
Gender
Error

Sum of
Squares

df

Mean Square

F

p

Partial η2

341.92
13.41
8.35
8.29

1
3
1
3

341.92
4.47
8.35
2.76

308.03
4.03
7.53
2.49

.000
.007**
.006**
.059

.333
.019
.012
.012

683.78

616

1.11

Note. Two-way ANOVA results show a main effect between age and drug abuse
problems, and gender and drug abuse problems.
** Statistical significance at the p < .01 level
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Table 12.
ANCOVA on CUDPOS scores by Age Cohort While Controlling for Childhood Trauma

Predictor

Sum of
Squares

df

Mean
Square

Corrected Model
Intercept
CTQb
Age Cohort
Error

11.980a
62.326
1.358
9.806
618.625

4
1
1
3
539

2.995
62.326
1.358
3.269
1.148

F

p

Partial η2

2.609
54.304
1.183
2.848

.035*
.000
.277
.037*

.019
.092
.002
.016

Note. ANCOVA results suggest that childhood trauma is a covariate that significantly
influences the relationship between CUDPOS and Age.
a. R Squared = .019 (Adjusted R Squared = .012)
b. Childhood Trauma Questionnaire (CTQ) scores were log transformed
* Statistical significance at the p < .01 level
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Figure 1.

Figure 1. A two-way ANOVA showing a significant interaction effect between Age
Cohort and Race on mean scores on the CUAPOS. Scores were log transformed to meet
statistical assumptions for ANOVA.
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